|
Market Closed -
NYSE
16:00:02 2026-08-26 EDT
|
5-day change | 1st Jan Change | ||
| 48.17 USD | -3.39% |
|
-7.38% | -49.48% |
| 08-26 | Health Care Down on Rotation Out of Biotech -- Health Care Roundup | DJ |
| 08-26 | Boston Scientific Shares Fall After Catheter Recall | MT |
| Market Cap | 72.26B 62.02B 58.21B 53.17B 100B 6,892B 101B 689B 267B 3,477B 271B 265B 11,516B | P/E 2026 * |
18x | P/E 2027 * | 19x |
|---|---|---|---|---|---|
| Enterprise Value | 80.98B 69.5B 65.23B 59.58B 112B 7,723B 113B 772B 299B 3,896B 304B 297B 12,905B | EV / Sales 2026 * |
3.79x | EV / Sales 2027 * | 3.48x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | -3.39% | ||
| 1 week | -7.38% | ||
| Current month | +3.08% | ||
| 1 month | +8.86% | ||
| 3 months | -16.43% | ||
| 6 months | -36.41% | ||
| Current year | -49.48% |
| 1 week | 46.9 |  | 50.9 |
| 1 month | 42.55 | | 52.99 |
| Current year | 42.2 | | 100.9 |
| 1 year | 42.2 | | 109.5 |
| 3 years | 42.2 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 2011-10-31 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 2025-06-29 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 2009-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 2016-05-02 |
Edward Ludwig
BRD | Director/Board Member | 74 | 2014-02-28 |
Ellen Zane
BRD | Director/Board Member | 74 | 2016-04-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/11/26 | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 8/10/26 | Other | Chief Financial Officer | 9,908 | 0.0007% | ||
| 8/5/26 | Buy | Director | 2,100 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.39% | -7.38% | -54.72% | -5.10% | 72.26B | |
| +0.89% | +3.29% | +29.73% | +17.01% | 232B | |
| -0.28% | +1.83% | +4.42% | -15.72% | 152B | |
| -0.38% | -6.86% | -21.90% | +24.49% | 131B | |
| -1.11% | -1.80% | -16.89% | -13.58% | 51.57B | |
| -0.10% | -1.63% | +11.70% | +19.18% | 52.38B | |
| +0.20% | -0.21% | +31.09% | +29.58% | 43.71B | |
| -0.07% | -0.40% | +39.86% | +51.51% | 40.72B | |
| -0.07% | +9.68% | +127.73% | +42.23% | 33.97B | |
| -0.38% | +2.19% | -17.35% | +46.41% | 34.13B | |
| Average | -0.47% | +2.18% | +13.37% | +19.60% | 84.42B | |
| Weighted average by Cap. | -0.24% | +1.01% | +8.55% | +13.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.37B 18.34B 17.21B 15.72B 29.67B 2,038B 29.81B 204B 78.94B 1,028B 80.22B 78.48B 3,405B | 22.33B 19.17B 17.99B 16.43B 31.01B 2,130B 31.16B 213B 82.5B 1,074B 83.84B 82.02B 3,559B |
| Net income | 3.84B 3.3B 3.09B 2.82B 5.33B 366B 5.36B 36.6B 14.18B 185B 14.41B 14.1B 612B | 3.69B 3.16B 2.97B 2.71B 5.12B 352B 5.14B 35.14B 13.62B 177B 13.84B 13.54B 587B |
| Net Debt | 8.72B 7.48B 7.02B 6.41B 12.1B 831B 12.16B 83.11B 32.21B 419B 32.73B 32.02B 1,389B | 5.45B 4.68B 4.39B 4.01B 7.57B 520B 7.61B 51.98B 20.14B 262B 20.47B 20.03B 869B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-26 | US$48.17 | -3.39% | 36,569,413 |
| 26-08-25 | US$49.86 | +1.73% | 17,368,920 |
| 26-08-24 | US$49.01 | -2.70% | 22,027,880 |
| 26-08-21 | US$50.37 | +2.03% | 35,992,162 |
| 26-08-20 | US$49.37 | -5.08% | 20,390,548 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
